Rigshospitalet Collaborates with BONESUPPORT on Bone Tumour Research

Copenhagen University Hospital, Rigshospitalet is to evaluate the CERAMENT™ platform for use in bone tumours and beyond in its latest research collaboration

BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, has announced a research collaboration with Rigshospitalet, Copenhagen University Hospital, the largest hospital in Denmark, whereby the institution will evaluate BONESUPPORT™'s platform technology, CERAMENT™, in the management of bone tumours.

Amongst other experiments, CERAMENT™ will be evaluated in combination with different substances in order to achieve enhanced bone healing.

“We are excited to evaluate the CERAMENT™ technology platform in this research collaboration,” said Michael Moerk Petersen, Professor, MD, DMSc, Rigshospitalet, who will oversee the study. “We believe CERAMENT™ can provide a safe and effective alternative long-term solution to these technologies.”

“BONESUPPORT™ is pleased to enter into this collaboration with such a prestigious medical institution,” said Dr. Eva Lidén, VP of Research and Development of BONESUPPORT™.  “Our CERAMENT™ technology platform continues to gain momentum with the physician community in Europe, and we will continue to invest in important research to validate our technology and improve upon the standard of care.”